Respiratory symptoms, asthma and levels of fractional exhaled nitric oxide in schoolchildren in the industrial areas of Estonia.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
10 Feb 2019
Historique:
received: 28 04 2018
revised: 26 08 2018
accepted: 27 08 2018
pubmed: 9 9 2018
medline: 21 11 2018
entrez: 9 9 2018
Statut: ppublish

Résumé

Exposure to air pollutants in the ambient environment has been associated with various respiratory symptoms, and with increased asthma diagnosis, in both children and adults. Most research to date has focussed on core pollutants, such as PM A total of 1326 schoolchildren from Ida-Viru, Lääne-Viru and Tartu Counties participated in a cross-sectional study, consisting of questionnaires on respiratory symptoms and asthma, as well as clinical examinations to measure FeNO. Dispersion modelling was used to characterize individual-level exposure to industrial air pollutants at each subject's home address. Associations between exposure and respiratory health were investigated using logistic regression analysis, and differences in results between regions were analysed using the Chi-squared test. The prevalence of respiratory symptoms (p < 0.05) in children living near (i.e. within 5 km) of an oil shale industry site in Ida-Viru County was 2-4 times higher than in children living in the reference area of Tartu County. Children exposed to 1 μg/m

Identifiants

pubmed: 30195132
pii: S0048-9697(18)33362-X
doi: 10.1016/j.scitotenv.2018.08.391
pii:
doi:

Substances chimiques

Air Pollutants 0
Hydrocarbons 0
Formaldehyde 1HG84L3525
Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-72

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

J Idavain (J)

University of Tartu, Institute of Family Medicine and Public Health, Ravila 19, 50411 Tartu, Estonia; National Institute for Health Development, Hiiu 42, 11619 Tallinn, Estonia. Electronic address: Jane.Idavain@ut.ee.

K Julge (K)

Tartu University Hospital Children's Clinic, N. Lunini 6, 51014 Tartu, Estonia; University of Tartu, Institute of Clinical Medicine, Department of Pediatrics, N. Lunini 6, 51014 Tartu, Estonia. Electronic address: Kaja.Julge@kliinikum.ee.

T Rebane (T)

Tartu University Hospital United Laboratories, L. Puusepa 8, 51014 Tartu, Estonia. Electronic address: Tiina.Rebane@kliinikum.ee.

A Lang (A)

University of Tartu, Institute of Biomedicine and Translational Medicine, Ravila 19, 50411 Tartu, Estonia. Electronic address: Aavo.Lang@ut.ee.

H Orru (H)

University of Tartu, Institute of Family Medicine and Public Health, Ravila 19, 50411 Tartu, Estonia; Umea University, Department of Public Health and Clinical Medicine, SE-901 87, Sweden. Electronic address: Hans.Orru@ut.ee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH